Search For "global pharma"
ACG launches ACGcaps™ NTone and ACGcaps™ TSafe Capsules
Updated : 5 years ago IST
Mumbai (Maharashtra) [India], March 25 (ANI/PRNewswire): ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, is delighted to announce its new ACGcaps™ NTone and ACGcaps™ TSafe range of capsules for the Nutraceutical marke
Read More
JIFFY.ai brings AUTOMATE Solution to the Pharmaceutical Industry via partn
Updated : 5 years ago IST
Bengaluru (Karnataka) [India], March 2 (ANI/PRNewswire): Global pharma major Lupin Limited (Lupin) and Silicon Valley-based enterprise automation start-up JIFFY.ai have announced a formalized partnership where JIFFY.ai will help to strategically expand Lupin's automation initiatives.
Read More
Glenmark receives one ANDA approval and two tentative ANDA approvals - Tad
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra)[India], December 31 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 2
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination (FDC) of its novel, patent protected and globally researched Sodium Glucose Co-Transporter Inhibitor (
Read More
PharmaLytica Virtual Expo Connect: India's largest pharmaceutical virtual
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 25 (ANI/PRNewswire): Informa Markets in India (formerly UBM India), organizers of CPhI / P-MEC India and PharmaLytica, the leading global pharma trade shows and conferences, is excited to present its first PharmaLytica Virtual Expo Connect from 30th Se
Read More
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 17 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the appointment of Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization for a period of five years wit
Read More
Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce th
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India.
Read More
Glenmark responds to DCGI letter seeking clarification on Fabiflu
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India] July 21 (ANI/PRNewswire): In response to the DCGI letter seeking clarification on FabiFlu, Glenmark Pharmaceuticals Ltd, a research-led, integrated global pharmaceutical company, has responded back. Please click the link below, to access the response letter.
Read More
Glenmark commences 1000 patients Post Marketing Surveillance study with CO
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 5 years, 10 months ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More
Pompeo hold talks with Jaishankar, highlights importance of US-India partn
Updated : 5 years, 12 months ago IST
Washington [US], Apr 01 (ANI): US Secretary of State Michael Pompeo on Tuesday held talks with External Affairs Minister S Jaishankar during which the former highlighted the importance of continued close cooperation between the United States and India to combat coronavirus by strengthening g
Read More